A Split Mouth Study to Evaluate Transcutaneous Electrical Nerve Stimulation as an Effective Non-pharmacological Approach in Managing Pain During Initial Orthodontic Treatment - A Randomized Controlled Trial
TENS
1 other identifier
interventional
40
1 country
1
Brief Summary
Orthodontic treatment often causes pain during the initial alignment stage which can lead to discomfort, reduced compliance, and slower treatment progress. Potential Solution: Transcutaneous Electrical Nerve Stimulation (TENS) is a non-invasive, non-pharmacological approach that uses mild electrical currents to stimulate nerves and potentially reduce pain. This study uses a split-mouth design, with each patient acting as their own control. One side of their mouth receives the TENS therapy, while the other receives a placebo treatment (minimum current below the therapeutic level). This allows for a direct comparison of TENS effectiveness without the influence of individual pain variations. Research Goal: The study aims to determine whether TENS can effectively manage pain during initial orthodontic treatment. This would offer a safe and natural alternative to pain medications, potentially improving patient comfort and treatment outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable pain
Started Mar 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 2, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 2, 2024
CompletedFirst Submitted
Initial submission to the registry
August 7, 2026
CompletedFirst Posted
Study publicly available on registry
August 12, 2026
CompletedAugust 12, 2026
August 1, 2026
7 months
August 7, 2026
August 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain will be measured after intervention at visual analogue scale
pateint after giving TENS treatment will be asked to measure their pain score for right and left side on visual analogue scale
pain will be marked on visual analogue scale at 0 hour , 6 hours, 24 hours, 48 hours
Study Arms (2)
TENS group
EXPERIMENTALParticipants in this arm will receive two 5-minute sessions of TENS therapy with a 2-minute break in between. Self-adhesive electrode pads will be placed on the designated cheek as determined by randomization. The TENS device will be set at intensity that is comfortable for the participant. The device will deliver electrical pulses through the electrodes to stimulate sensory nerves and potentially reduce pain. Participants will receive this TENS therapy application immediately after the initial placement of the alignment archwire Both groups will be instructed to mark their pain levels on a visual analog scale (VAS) at 0, 6, 24, and 48 hours after the initial archwire placement.
Placebo/Control group
SHAM COMPARATORParticipants in this arm will receive a similar treatment that mimics the TENS application but with minimal current to maintain participant blinding. Similar to the TENS group, self-adhesive electrode pads will be placed on the designated cheek. The placebo device will be set at a very low intensity that only feels like a slight tingling sensation. This sham treatment serves as a control, allowing comparison of any pain reduction to the effects of real TENS therapy.Participants will receive this placebo treatment application on the same schedule as the TENS group - immediately after archwire placement
Interventions
Trancutaneous electrical nerve stimulation device with self-adhesive pads will be placed on patients cheeks. Experimental side will recveive active TENS treatment and other side will receive treatment with intensity of TENS set at low intensity (subtherapeutic)
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Foundation University Islamabad
Islamabad, Federal, 44000, Pakistan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- split-mouth study design interventional or placebo control side will be selected randomly through sealed envelope by an independent researcher not involved in the study .
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
August 7, 2026
First Posted
August 12, 2026
Study Start
March 20, 2024
Primary Completion
October 2, 2024
Study Completion
December 2, 2024
Last Updated
August 12, 2026
Record last verified: 2026-08